secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001140361-23-043736
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharmaceuticals reduces ATM offering capacity to $180M, suspends sales
-----------------------------------------------------------------------------

- Original $200M ATM capacity reduced to $180M via amendment to Sales Agreement with Cowen.
- Company sold $65.9M of shares to date; remaining availability is ~$114.1M.
- ATM prospectus suspended; no further sales until new prospectus or registration statement filed.
- Amendment effective September 12, 2023; Amended Sales Agreement remains in full force.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123043736/0001140361-23-043736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123043736/ny20010507x4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-043736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer